Hemant Surgical's SME IPO opens on May 24; check price band and other details

Hemant Surgical's SME IPO opens on May 24; check price band and other details

Hemant Surgical incorporated in 1989, is a Mumbai headquartered Company having more than three decades experience in medical equipment and disposables.

Advertisement
The issue of Hemant Surgical Industries comprises up to 27,60,000 equity shares with a face value of Rs 10 each, aggregating to Rs 24.84 crore at the upper limit of the price band.The issue of Hemant Surgical Industries comprises up to 27,60,000 equity shares with a face value of Rs 10 each, aggregating to Rs 24.84 crore at the upper limit of the price band.
Pawan Kumar Nahar
  • May 19, 2023,
  • Updated May 19, 2023 4:01 PM IST

The initial public offering (IPO) of Hemant Surgical Industries will open for subscription on May 24 (Wednesday) It will close on Friday, May 26. The company will sell its shares in the price band of Rs 85-90 apiece.

The issue of Hemant Surgical Industries comprises up to 27,60,000 equity shares with a face value of Rs 10 each, aggregating to Rs 24.84 crore at the upper limit of the price band. The issue is entirely a fresh stake sale, which is likely to make Dalal Street debut on June 5.

Advertisement

The company intends to utilise the proceeds from the Issue for funding capital expenditure towards the installation of additional plant and machinery, funding to meet working capital requirements, and general corporate purpose.

The Book Running Lead Managers to the IPO are Hem Securities, while Bigshare Services is the registrar to the issue. Shares of the company will be listed on the SME platform of BSE.

The portion of the issue being not less than 35 per cent has been reserved for the retail investors. The company has fixed QIB quota at 50 per cent and NII quota at 15 per cent. However, 1,44,000 equity shares are reserved for Hem Finlease who is the market maker for the issue.

Advertisement

Hemant Surgical incorporated in 1989, is a Mumbai headquartered Company having more than three decades experience in medical equipment and disposables. Its products cater to renal care, cardiovascular disease, respiratory disease, critical care and radiology. The company has ISO Certified one manufacturing unit and two assembly units in Maharashtra. 

 

Also read: PNB Q4 results: PSU lender reports manifold jump in profit, NII rises 30%

Also read: Bandhan Bank Q4 results: Profit plunges 57% to Rs 808 crore; lender declares Rs 1.50 dividend

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

The initial public offering (IPO) of Hemant Surgical Industries will open for subscription on May 24 (Wednesday) It will close on Friday, May 26. The company will sell its shares in the price band of Rs 85-90 apiece.

The issue of Hemant Surgical Industries comprises up to 27,60,000 equity shares with a face value of Rs 10 each, aggregating to Rs 24.84 crore at the upper limit of the price band. The issue is entirely a fresh stake sale, which is likely to make Dalal Street debut on June 5.

Advertisement

The company intends to utilise the proceeds from the Issue for funding capital expenditure towards the installation of additional plant and machinery, funding to meet working capital requirements, and general corporate purpose.

The Book Running Lead Managers to the IPO are Hem Securities, while Bigshare Services is the registrar to the issue. Shares of the company will be listed on the SME platform of BSE.

The portion of the issue being not less than 35 per cent has been reserved for the retail investors. The company has fixed QIB quota at 50 per cent and NII quota at 15 per cent. However, 1,44,000 equity shares are reserved for Hem Finlease who is the market maker for the issue.

Advertisement

Hemant Surgical incorporated in 1989, is a Mumbai headquartered Company having more than three decades experience in medical equipment and disposables. Its products cater to renal care, cardiovascular disease, respiratory disease, critical care and radiology. The company has ISO Certified one manufacturing unit and two assembly units in Maharashtra. 

 

Also read: PNB Q4 results: PSU lender reports manifold jump in profit, NII rises 30%

Also read: Bandhan Bank Q4 results: Profit plunges 57% to Rs 808 crore; lender declares Rs 1.50 dividend

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Read more!
Advertisement